Atlas Trials

Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder

Clinical trial NCT00290914 · COMPLETED

Trial details

NCT number
NCT00290914
Sponsor
Pharmacology Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.